خانه › سرطان ریه › فلوریدا › Tampa
آزمایشهای بالینی سرطان ریه در Tampa، FL
29 مطالعه برای سرطان ریه در مراکز Tampa (در شعاع حدود ۳۰ مایل) در جستجوی شرکتکننده هستند. یک مطالعه را باز کنید تا شرایط شرکت و نحوه تماس با تیم پژوهشی را ببینید.
متن رسمی مطالعه (انگلیسی)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
در حال جذب شرکتکنندهمرحله 3
- Moffitt Cancer Center, Tampa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
در حال جذب شرکتکنندهمطالعه مشاهدهایپذیرش داوطلبان سالم
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
در حال جذب شرکتکنندهمرحله 3
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
در حال جذب شرکتکنندهمرحله 1
- Moffitt Cancer Center, Tampa
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
در حال جذب شرکتکنندهمرحله 3
- Moffitt Cancer Center-International Plaza, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- و 1 مورد دیگر
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
در حال جذب شرکتکنندهمرحله 3
- H Lee Moffitt Cancer Center and Research Institute, Tampa
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
در حال جذب شرکتکنندهمرحله 3
- Florida Cancer Specialists, Tampa
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
در حال جذب شرکتکنندهمرحله 2/3
- Local Institution - 0523, Tampa
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
در حال جذب شرکتکنندهمرحله 2/3
- H. Lee Moffit Cancer center and research institute, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
در حال جذب شرکتکنندهمرحله 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
در حال جذب شرکتکنندهمرحله 1/2
- Moffitt Cancer Center, Tampa
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
در حال جذب شرکتکنندهمرحله 1
- Moffitt Cancer Center, Tampa
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
در حال جذب شرکتکنندهمرحله 1/2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
در حال جذب شرکتکنندهمرحله 1/2
- Avenzo Therapeutics Recruiting Site, Tampa
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
در حال جذب شرکتکنندهمرحله 3
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
در حال جذب شرکتکننده
- James A. Haley Veterans' Hospital, Tampa
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
در حال جذب شرکتکنندهمرحله 1/2
- H Lee Moffitt Cancer Center and Research Institute, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
در حال جذب شرکتکنندهمرحله 1
- Moffitt Cancer Center, Tampa
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
در حال جذب شرکتکنندهمرحله 2
- H Lee Moffitt Cancer Center and Research Institute, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
در حال جذب شرکتکنندهمرحله 1/2
- Moffitt Cancer Center, Tampa
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
در حال جذب شرکتکنندهمرحله 1/2
- Moffitt Cancer Center, Tampa
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
در حال جذب شرکتکنندهمرحله 2
- Moffitt Cancer Center, Tampa
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
در حال جذب شرکتکنندهمرحله 1
- Lee Moffitt Cancer Center, Tampa
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
در حال جذب شرکتکنندهمرحله 1/2
- Moffitt Cancer Center, Tampa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
در حال جذب شرکتکنندهمرحله 2
- Moffitt Cancer Center, Tampa
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
در حال جذب شرکتکنندهمرحله 2/3
- Moffitt Cancer Center, Tampa
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
در حال جذب شرکتکنندهپذیرش داوطلبان سالم
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
در حال جذب شرکتکنندهمطالعه مشاهدهای
- Massive Bio SYNERGY-AI site, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
در حال جذب شرکتکنندهمرحله 1/2
- Moffitt Cancer Center, Tampa
آزمایشهای سرطان ریه در سایر شهرها
- Houston, TX78 مطالعه
- Boston, MA62 مطالعه
- New York City, NY60 مطالعه
- Los Angeles, CA45 مطالعه
- Washington, DC41 مطالعه
- Arlington, VA41 مطالعه
- Chicago, IL41 مطالعه
- Nashville, TN40 مطالعه
- Baltimore, MD40 مطالعه
- St. Louis, MO39 مطالعه
- Columbus, OH37 مطالعه
- Philadelphia, PA36 مطالعه
سایر مطالعات در Tampa
- سرطان ریه غیرسلول کوچک51 مطالعه
- سرطان پستان43 مطالعه
- سرطان (همه انواع)39 مطالعه
- سرطان کولورکتال33 مطالعه
- سرطان متاستاتیک29 مطالعه
- لوکمیه حاد میلویید29 مطالعه
- سرطان لوزالمعده26 مطالعه
- سرطان تخمدان21 مطالعه
- سندرمهای میلودیسپلاستیک19 مطالعه
- ملانوم19 مطالعه
- نارسایی قلبی18 مطالعه
- سرطان پروستات18 مطالعه
از ClinicalTrials.gov، دادهها در تاریخ 5 اکتبر 2026 دریافت شده است. هر مطالعه شرایط اختصاصی خود را دارد؛ تیم پژوهشی تصمیم میگیرد چه کسانی میتوانند شرکت کنند.